Simulations Plus outlines $79M–$82M FY 2026 revenue target as AI and cloud integration strategy advances
…
19,170$
-1,74%
Echtzeit-Aktienkurs Simulations Plus
Bid:
Ask:
Nachrichten zur Simulations Plus Aktie
Simulations Plus, Inc. (SLP) Q4 2025 Earnings Call Transcript
…
Simulations Plus (SLP) Reports Next Week: Wall Street Expects Earnings Growth
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
Wall Street Analysts Believe Simulations Plus (SLP) Could Rally 33.57%: Heres is How to Trade
The consensus price target hints at a 33.6% upside potential for Simulations Plus (SLP). While empirical research shows that this…
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Oct. 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
SIMULATIONS PLUS REMINDER Bragar Eagel & Squire, P.C. Urges Investors in into Simulations Plus, Inc. to Contact the Firm Regarding the Ongoing Investigation on Behalf of Stockholders
Simulations Plus posted weak Q3 2025 results, including a $77.2M impairment and cut guidance, sending shares down 25.8% to $12.97…
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Oct. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm,…
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, Aug. 03, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
SLP Investor News: If You Have Suffered Losses in Simulations Plus, Inc. (NASDAQ: SLP), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
NEW YORK, July 26, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law…
Simulations Plus, Inc. (SLP) Q3 2025 Earnings Call Transcript
…
Simulations Plus Q3 2025 Earnings Preview
…
Simulations Plus (SLP) Earnings Expected to Grow: What to Know Ahead of Next Weeks Release
Simulations Plus (SLP) doesnt possess the right combination of the two key ingredients for a likely earnings beat in its…
SLP Cuts FY25 Revenue Outlook, Begins Strategic Reorganization
Simulations Plus lowers FY25 revenue forecast and restructures operations as biotech headwinds hit services demand.…
Simulations Plus: KI-Simulation statt Tierversuchen! FDA fördert neuartige Techniken bei der Medikamentenforschung! Aktie zieht an!
Der Sektor "Healthcare" liegt aktuell im Mittelfeld aller Sektoren. In der letzten Woche gab es eine bahnbrechende Mitteilung durch die…
Simulations Plus, Inc. 2025 Q2 - Results - Earnings Call Presentation
…
Simulations Plus, Inc. (SLP) Q2 2025 Earnings Call Transcript
…
SLPs Q2 Earnings Top, Sales Up Y/Y Despite Industry Headwinds
Simulations Plus fiscal Q2 2025 performance gains from its strong software solutions and services portfolio amid limited customer funding.…
Simulations Plus (SLP) Tops Q2 Earnings and Revenue Estimates
Simulations Plus (SLP) delivered earnings and revenue surprises of 24% and 3.11%, respectively, for the quarter ended February 2025. Do…
Simulations Plus, Inc. (SLP) Q1 2025 Earnings Call Transcript
…
Simulations Plus, Inc. 2025 Q1 - Results - Earnings Call Presentation
…
Simulations Plus (SLP) Lags Q1 Earnings Estimates
Simulations Plus (SLP) delivered earnings and revenue surprises of -5.56% and 1.25%, respectively, for the quarter ended November 2024. Do…
Simulations Plus, Inc. (SLP) Q4 2024 Earnings Call Transcript
…
Simulations Plus (SLP) Restructures Business Unit Post-Acquisitions
Simulations Plus (SLP) enhances its business structure after recent acquisitions, and appoints new leaders for its redesigned business units…
Simulations Plus (SLP) Ties Up With ICCS for Chemical Safety
Simulations Plus (SLP) announces a collaboration with ICCS on a research initiative to advance animal-free safety assessment of new chemicals…
Simulations Plus (SLP) Q3 Earnings & Revenues Beat Estimates
Simulations Plus (SLP) fiscal third-quarter revenues are driven by strength in Software and Services units.…
Simulations Plus, Inc. (SLP) Q3 2024 Earnings Call Transcript
…
Simulations Plus, Inc. 2024 Q3 - Results - Earnings Call Presentation
…
After-hours movers: Tesla, First Foundation, Simulations Plus, and Rivian By Investing.com
After-hours movers: Tesla, First Foundation, Simulations Plus, and Rivian…
Simulations Plus (SLP) Buys Pro-ficiency Holdings for $100M
Simulation Plus (SLP) acquires Pro-ficiency from QHP Capital for $100 million in an all-cash transaction.…
Simulations Plus (SLP) Launches GPX to Advance PBPK Modeling
Simulations Plus (SLP) unveils GastroPlus X, which significantly reduces time spent on model setup, data management, and reformatting results.…
Simulations Plus (SLP) DILIsym Software Licenses Renewed by FDA
For the seventh consecutive year, the FDA has renewed Simulations Plus (SLP) license to the DILIsym software system for facilitating…
Simulations Plus, Inc. 2024 Q2 - Results - Earnings Call Presentation
…
Simulations Plus, Inc. (SLP) Q2 2024 Earnings Call Transcript
…
Simulations Plus (SLP) Q2 Earnings & Revenues Beat Estimates
Simulations Plus (SLP) second-quarter fiscal 2024 top line is driven by higher revenues in the Software and Services business segments.…
Simulations Plus (SLP) Q2 Earnings and Revenues Surpass Estimates
Simulations Plus (SLP) delivered earnings and revenue surprises of 11.11% and 7.24%, respectively, for the quarter ended February 2024. Do…
Simulations Plus Q2 2024 Earnings Preview
…
Simulations Plus (SLP) to Report Q2 Earnings: Whats in Store?
Simulations Plus (SLP) fiscal second-quarter performance is likely to have benefited from momentum across Software and Services business segments.…